122 related articles for article (PubMed ID: 18306371)
61. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
62. Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.
Gugger A; Barnhill RL; Seifert B; Dehler S; Moch H; Lugassy C; Marques-Maggio E; Rushing EJ; Mihic-Probst D
PLoS One; 2016; 11(5):e0156115. PubMed ID: 27213536
[TBL] [Abstract][Full Text] [Related]
63. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.
Orlow I; Reiner AS; Thomas NE; Roy P; Kanetsky PA; Luo L; Paine S; Armstrong BK; Kricker A; Marrett LD; Rosso S; Zanetti R; Gruber SB; Anton-Culver H; Gallagher RP; Dwyer T; Busam K; Begg CB; Berwick M;
Carcinogenesis; 2016 Jan; 37(1):30-8. PubMed ID: 26521212
[TBL] [Abstract][Full Text] [Related]
64. Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis.
Stanelle EJ; Busam KJ; Rich BS; Christison-Lagay ER; Dunkel IJ; Marghoob AA; Halpern A; Coit DG; La Quaglia MP
J Pediatr Surg; 2015 Jun; 50(6):1019-23. PubMed ID: 25819019
[TBL] [Abstract][Full Text] [Related]
65. High nevus counts confer a favorable prognosis in melanoma patients.
Ribero S; Davies JR; Requena C; Carrera C; Glass D; Rull R; Vidal-Sicart S; Vilalta A; Alos L; Soriano V; Quaglino P; Traves V; Newton-Bishop JA; Nagore E; Malvehy J; Puig S; Bataille V
Int J Cancer; 2015 Oct; 137(7):1691-8. PubMed ID: 25809795
[TBL] [Abstract][Full Text] [Related]
66. Is oestrogen an important player in melanoma progression?
Janik ME; Bełkot K; Przybyło M
Contemp Oncol (Pozn); 2014; 18(5):302-6. PubMed ID: 25477750
[TBL] [Abstract][Full Text] [Related]
67. Epidemiological and histopathological profile of cutaneous melanoma at a center in northeastern Brazil from 2000 to 2010.
Vilanova CM; Lages RB; Ribeiro SM; Almeida IP; Santos LG; Vieira SC
An Bras Dermatol; 2013; 88(4):545-53. PubMed ID: 24068125
[TBL] [Abstract][Full Text] [Related]
68. Impact of age on the management of primary melanoma patients.
Fleming NH; Tian J; Vega-Saenz de Miera E; Gold H; Darvishian F; Pavlick AC; Berman RS; Shapiro RL; Polsky D; Osman I
Oncology; 2013; 85(3):173-81. PubMed ID: 24008821
[TBL] [Abstract][Full Text] [Related]
69. Age as a prognostic factor in patients with localized melanoma and regional metastases.
Balch CM; Soong SJ; Gershenwald JE; Thompson JF; Coit DG; Atkins MB; Ding S; Cochran AJ; Eggermont AM; Flaherty KT; Gimotty PA; Johnson TM; Kirkwood JM; Leong SP; McMasters KM; Mihm MC; Morton DL; Ross MI; Sondak VK
Ann Surg Oncol; 2013 Nov; 20(12):3961-8. PubMed ID: 23838920
[TBL] [Abstract][Full Text] [Related]
70. Cancer survival and excess mortality estimates among adolescents and young adults in Western Australia, 1982-2004: a population-based study.
Haggar FA; Pereira G; Preen DD; Holman CD; Einarsdottir K
PLoS One; 2013; 8(2):e55630. PubMed ID: 23405184
[TBL] [Abstract][Full Text] [Related]
71. Sex-dependent liver colonization of human melanoma in SCID mice--role of host defense mechanisms.
Dobos J; Mohos A; Tóvári J; Rásó E; Lőrincz T; Zádori G; Tímár J; Ladányi A
Clin Exp Metastasis; 2013 Apr; 30(4):497-506. PubMed ID: 23203681
[TBL] [Abstract][Full Text] [Related]
72. Patterns of response in patients with pretreated metastatic melanoma who received ipilimumab 3 mg/kg in a European expanded access program: five illustrative case reports.
Wilgenhof S; Du Four S; Everaert H; Neyns B
Cancer Invest; 2012 Dec; 30(10):712-20. PubMed ID: 23043499
[TBL] [Abstract][Full Text] [Related]
73. Associations between environmental factors and incidence of cutaneous melanoma. Review.
Volkovova K; Bilanicova D; Bartonova A; Letašiová S; Dusinska M
Environ Health; 2012 Jun; 11 Suppl 1(Suppl 1):S12. PubMed ID: 22759494
[TBL] [Abstract][Full Text] [Related]
74. Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study.
Fridberg M; Jonsson L; Bergman J; Nodin B; Jirström K
Biol Sex Differ; 2012 Jul; 3(1):16. PubMed ID: 22748166
[TBL] [Abstract][Full Text] [Related]
75. Time course and pattern of metastasis of cutaneous melanoma differ between men and women.
Mervic L
PLoS One; 2012; 7(3):e32955. PubMed ID: 22412958
[TBL] [Abstract][Full Text] [Related]
76. Malignant melanoma in the elderly: different regional disease and poorer prognosis.
Macdonald JB; Dueck AC; Gray RJ; Wasif N; Swanson DL; Sekulic A; Pockaj BA
J Cancer; 2011; 2():538-43. PubMed ID: 22084644
[TBL] [Abstract][Full Text] [Related]
77. Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Lucisano G; Labianca R; Marchesi L; Merelli B; Robone S; Poletti P; Milesi L; Tondini C
Mayo Clin Proc; 2011 Feb; 86(2):113-9. PubMed ID: 21282485
[TBL] [Abstract][Full Text] [Related]
78. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
Tímár J; Gyorffy B; Rásó E
Clin Exp Metastasis; 2010 Aug; 27(6):371-87. PubMed ID: 20177751
[TBL] [Abstract][Full Text] [Related]
79. Epidemiology and treatment of melanoma in elderly patients.
Tsai S; Balch C; Lange J
Nat Rev Clin Oncol; 2010 Mar; 7(3):148-52. PubMed ID: 20142815
[TBL] [Abstract][Full Text] [Related]
80. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
Newton-Bishop JA; Beswick S; Randerson-Moor J; Chang YM; Affleck P; Elliott F; Chan M; Leake S; Karpavicius B; Haynes S; Kukalizch K; Whitaker L; Jackson S; Gerry E; Nolan C; Bertram C; Marsden J; Elder DE; Barrett JH; Bishop DT
J Clin Oncol; 2009 Nov; 27(32):5439-44. PubMed ID: 19770375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
